Database Query Results : , , ascitic
ascitic, ascitic fluid: Click to Expand ⟱
| Source: |
| Type: |
Ascitic fluid is a type of fluid that accumulates in the abdominal cavity.
In cancer patients, ascitic fluid can be a sign of advanced disease. Cancer cells can spread to the abdominal cavity and produce fluid, leading to an accumulation of ascitic fluid.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
*VEGF↓, *angioG↓, *ascitic↓, *Sp1/3/4↓,
TumCG↓, TumVol↓, Weight∅, ascitic↓, TumMeta↓, Ki-67↓, CD31↓, NF-kB↓, COX2↓, Bcl-2↓, Bcl-xL↓, IAP1↓, survivin↓, cycD1/CCND1↓, ICAM-1↓, MMP9↓, CXCR4↓, VEGF↓,
*Inflam↓, AntiCan↑, *MAPK↑, *Ca+2↝, p‑ERK↓, TumCI↓, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, p‑RB1↓, *NF-kB↓, *TNF-α↓, NF-kB↓, IKKα↓, MCP1↓, IL1α↓, MIP2↓, VEGF↓, Tf↓, COX2↓, MMP9↓, CXCR4↓, VEGF↓, eff↑, PPARα↓, lipid-P?, STAT3↓, TOP1↓, TOP2↑, 5HT↓, p‑PDGFR-BB↓, PDGF↓, AR↓, DR5↑, angioG↓, DR4↑, Casp3↑, Casp8↑, cl‑PARP↑, eff↑, chemoPv↑, Wnt↓, β-catenin/ZEB1↓, ascitic↓, Let-7↑, miR-200b↑, eff↑, MMP1↓, MMP2↓, eff↑, BioAv↓, BioAv↑, Half-Life↓, toxicity↓, Dose↑, BioAv↑, ChemoSen↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vivo, |
Ovarian, |
SKOV3 |
|
|
|
VEGF↓, Hif1a↓, p‑STAT3↓, p‑Akt↓, angioG↓, TumCG↓, TumW↓, ascitic↓,
| - |
vitro+vivo, |
lymphoma, |
NA |
|
|
|
OS↑, ascitic↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned ⓘ
chemoPv↑, 1,
Redox & Oxidative Stress ⓘ
lipid-P?, 1,
Metal & Cofactor Biology ⓘ
Tf↓, 1,
Core Metabolism/Glycolysis ⓘ
PPARα↓, 1,
Cell Death ⓘ
p‑Akt↓, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 1, Casp8↑, 1, DR4↑, 1, DR5↑, 1, IAP1↓, 1, survivin↓, 1,
DNA Damage & Repair ⓘ
cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 2, cycE/CCNE↓, 1, p‑RB1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↓, 1, Let-7↑, 1, STAT3↓, 1, p‑STAT3↓, 1, TOP1↓, 1, TOP2↑, 1, TumCG↓, 2, Wnt↓, 1,
Migration ⓘ
CD31↓, 1, Ki-67↓, 1, miR-200b↑, 1, MMP1↓, 1, MMP2↓, 1, MMP9↓, 2, PDGF↓, 1, TumCI↓, 1, TumMeta↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, Hif1a↓, 1, p‑PDGFR-BB↓, 1, VEGF↓, 4,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, CXCR4↓, 2, ICAM-1↓, 1, IKKα↓, 1, IL1α↓, 1, MCP1↓, 1, MIP2↓, 1, NF-kB↓, 2,
Synaptic & Neurotransmission ⓘ
5HT↓, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, ChemoSen↑, 1, Dose↑, 1, eff↑, 4, Half-Life↓, 1,
Clinical Biomarkers ⓘ
AR↓, 1, ascitic↓, 4, Ki-67↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, OS↑, 1, toxicity↓, 1, TumVol↓, 1, TumW↓, 1, Weight∅, 1,
Total Targets: 66
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
MAPK↑, 1,
Kinase & Signal Transduction ⓘ
Sp1/3/4↓, 1,
Migration ⓘ
Ca+2↝, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Clinical Biomarkers ⓘ
ascitic↓, 1,
Total Targets: 9
Scientific Paper Hit Count for: ascitic, ascitic fluid
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:622 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page